Login

Mark Iwicki, chairman and CEO, Kala Pharmaceuticals Inc 00:00:00

Share On Facebook Share On Twitter

Mark Iwicki, chairman and CEO, Kala Pharmaceuticals Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
provides investable assets for diverse angel investors to fund tomorrow's companies|Mark Kraynak,Founding Partner,Acrew Capital
00:10:00
Voyager Life PLC Launches UK's First Refillable CBD Products, Backed by Deputy First Minister John Swinney | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Pebble Beach Systems CEO Peter Mayhead Explores International Broadcasting Market and Specialized Content Solutions.
00:10:00
Capital Invests in people building visual technology|Evan Nisselson,General Partner,LDV Capital
00:10:00
David Garofalo discusses how royalty companies fill an important gap | David Garofalo, Chairman and CEO, Gold Royalty Corp. (IE)
00:10:00
Rincon Resources CEO Discusses Exploration Plans and Prospects for 2021 on Assay TV
00:10:00
Optimizing Investment Time Horizons: Insights from Ken Fisher|  Ken Fisher, Chairman, Fisher Investments.
00:10:00
Unlocking Orebody Insights: Data-Driven Mine to Mill Reconciliation | Jeff More - President and CEO of MineSense Technologies Ltd.
00:10:00
AIM Act Webinar: Transitioning to Sustainable Refrigerants | Brian Coleman - CEO of Hudson Technologies Company
00:00:00
AdAlta Phase I Extension Study Results - Tim Oldham, MD, Adalta Ltd
00:10:00
Explaining Double Trigger RSUs: Key Differences and IPO Impact | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Bill Cram, CFA: Exploring Aristotle’s Timeless Definition of Quality

© 2017 - Neuhu+